Home » Medical Devices » U.S. Peripheral Vascular Devices Market

U.S. Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 68761 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
U.S. Peripheral Vascular Devices Market Size 2023  USD 2,945.00 Million
U.S. Peripheral Vascular Devices Market, CAGR  6.70%
U.S. Peripheral Vascular Devices Market Size 2032  USD 4,947.26 Million

Market Overview

The U.S. Peripheral Vascular Devices Market is projected to grow from USD 2,945.00 million in 2023 to USD 4,947.26 million by 2032, at a compound annual growth rate (CAGR) of 6.70%.

The U.S. Peripheral Vascular Devices market is driven by the rising prevalence of peripheral artery diseases (PAD) and the increasing geriatric population, which are major risk factors for vascular disorders. Technological advancements, such as minimally invasive procedures and improved device designs, are enhancing the efficacy and safety of treatments, contributing to market growth. Additionally, the growing focus on early diagnosis and preventive care is expanding the adoption of peripheral vascular devices. Trends such as the increasing popularity of bioresorbable devices and the shift towards outpatient settings for vascular procedures are further shaping the market. The integration of advanced materials and the development of next-generation stents and catheters are expected to boost treatment outcomes, fostering further market expansion. Furthermore, supportive reimbursement policies and growing healthcare investments are creating a conducive environment for the widespread adoption of these devices. These factors combined are likely to fuel the market’s growth in the coming years.

The U.S. Peripheral Vascular Devices market exhibits strong regional demand, driven by healthcare infrastructure, aging populations, and rising incidences of vascular diseases such as peripheral artery disease (PAD). Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, and Becton, Dickinson and Company, among others. These companies are leading innovation in vascular device technologies, offering a range of products such as angioplasty balloons, stents, catheters, and guidewires. They are focused on expanding their presence across the U.S. through partnerships, acquisitions, and a strong emphasis on research and development. Additionally, the increasing adoption of minimally invasive procedures in hospitals, ambulatory surgical centers, and specialty clinics is accelerating the demand for these devices. With ongoing advancements and a competitive landscape, key players are strategically positioning themselves to capture the growing market for peripheral vascular devices in the U.S.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The U.S. Peripheral Vascular Devices market was valued at USD 2,945.00 million in 2023 and is expected to reach USD 4,947.26 million by 2032, growing at a CAGR of 6.70%.
  • Increasing adoption of minimally invasive procedures is driving market growth, as patients and healthcare providers seek less invasive treatment options.
  • Growing prevalence of peripheral artery disease (PAD) and lifestyle-related risk factors like obesity and diabetes is fueling demand for vascular interventions.
  • The shift toward outpatient and ambulatory care centers is accelerating the adoption of peripheral vascular devices, offering cost-effective alternatives.
  • Technological advancements, such as drug-eluting stents and bioresorbable devices, are enhancing treatment efficacy and patient outcomes.
  • Key players like Abbott Laboratories, Boston Scientific Corporation, and Medtronic plc dominate the competitive landscape, focusing on innovation and strategic partnerships.
  • Market restraints include the high cost of advanced devices and regulatory challenges, which may limit access and adoption across certain patient populations.

Market Drivers

Technological Advancements in Medical Devices

Technological innovation is another key factor driving the growth of the U.S. Peripheral Vascular Devices market. Advancements in device design, such as the development of drug-eluting stents, bioresorbable vascular scaffolds, and advanced catheters, are enhancing treatment outcomes and patient safety. For instance, the development of the Shockwave Javelin Peripheral IVL Catheter has shown positive clinical results for treating calcified lesions in PAD. Minimally invasive techniques have become more common, reducing recovery time and improving patient satisfaction. These innovations are leading to the widespread adoption of vascular devices for treating various peripheral vascular diseases, thus contributing to market expansion.

Aging Population and Rising Healthcare Expenditures

The aging U.S. population is a significant driver of the peripheral vascular device market. As the number of elderly individuals increases, so does the incidence of age-related vascular diseases. For instance, by 2034, Americans aged 65 and older will exceed 77 million. Older adults are more susceptible to conditions like PAD, which in turn fuels the demand for peripheral vascular interventions. Furthermore, increased healthcare expenditures and better access to healthcare services have improved the availability and adoption of these devices, making them more accessible to a larger patient population and driving market growth.

Growing Prevalence of Peripheral Artery Disease (PAD)

One of the primary drivers of the U.S. Peripheral Vascular Devices market is the increasing incidence of peripheral artery disease (PAD). As a condition predominantly affecting the elderly and those with risk factors like diabetes, hypertension, and smoking, PAD is contributing significantly to the demand for vascular interventions. With PAD affecting millions of Americans, the need for effective treatments such as stents, balloons, and catheters is rising. As the disease continues to spread, the market for peripheral vascular devices is expected to expand steadily.

Supportive Reimbursement Policies

Supportive reimbursement policies play a crucial role in driving the U.S. Peripheral Vascular Devices market. As insurers and government programs like Medicare expand coverage for peripheral vascular treatments, more patients are able to access these life-changing procedures. For example, the Centers for Medicare & Medicaid Services (CMS) has made significant changes to reimbursement policies, increasing coverage for various peripheral vascular procedures. The financial support from insurance programs has made vascular device procedures more affordable for a broader segment of the population. This increase in insurance coverage and reimbursement rates is expected to drive greater adoption and utilization of peripheral vascular devices, thus positively impacting market growth.

Market Trends

Shift Toward Minimally Invasive Procedures

A significant trend in the U.S. Peripheral Vascular Devices market is the growing preference for minimally invasive procedures. These procedures offer patients reduced recovery times, smaller incisions, and lower risk of complications compared to traditional open surgeries. For instance, minimally invasive procedures have shown considerable benefits, with many surgeons performing over 100 endoscopies annually. As technology has advanced, devices such as balloon angioplasty catheters, stents, and thrombectomy tools have been refined to support less invasive techniques. This trend is leading to an increasing adoption of these devices in the treatment of peripheral vascular diseases, which are less disruptive to patients’ daily lives and improve overall outcomes.

Focus on Bioresorbable Vascular Devices

Another notable trend is the development of bioresorbable vascular devices. These innovative products, such as bioresorbable stents and scaffolds, are designed to dissolve naturally in the body over time, reducing the risk of long-term complications and the need for additional surgeries. Bioresorbable devices are gaining attention due to their ability to offer temporary support to vessels while promoting natural healing. For instance, the U.S. bioresorbable coronary stents market is projected to grow significantly, reflecting the increasing demand for safer, more effective treatment options. As the demand for safer, more effective treatment options grows, the trend toward bioresorbable devices is expected to drive market growth.

Increased Adoption of Drug-Eluting Stents

Drug-eluting stents (DES) have become a critical innovation in the treatment of peripheral artery disease (PAD). These stents are coated with medication that helps prevent the re-narrowing of the artery, reducing the risk of restenosis. The U.S. market is witnessing a shift toward the adoption of DES, driven by their ability to deliver better long-term outcomes for patients. As physicians and healthcare providers increasingly recognize the benefits of these stents, their adoption rate is expected to rise, further advancing the market for peripheral vascular devices.

Expansion of Outpatient and Ambulatory Care Settings

A growing trend in the U.S. healthcare landscape is the shift toward outpatient and ambulatory care centers for vascular procedures. With advancements in vascular device technologies and procedural techniques, more peripheral vascular interventions are being conducted in outpatient settings rather than hospitals. This shift is driven by cost-effectiveness, shorter recovery times, and patient convenience. As outpatient clinics and surgical centers expand their capabilities, they are contributing to the growing demand for peripheral vascular devices, driving market growth in these alternative care settings.

Market Challenges Analysis

High Cost of Peripheral Vascular Devices

One of the significant challenges facing the U.S. Peripheral Vascular Devices market is the high cost of advanced devices. Many peripheral vascular interventions, including stents, balloons, and catheters, require substantial financial investments in research, development, and manufacturing. For instance, the development of new stent technologies involves extensive clinical trials and regulatory approvals, which contribute to the high costs. These costs are often passed on to healthcare providers and patients, making treatments less affordable, especially for those without adequate insurance coverage. Although the growing demand for these devices is helping to offset some of these expenses, the high price remains a barrier, limiting access to treatment for certain patient populations. Moreover, the introduction of innovative but expensive technologies, such as bioresorbable stents and drug-eluting devices, further exacerbates the cost burden, presenting a significant challenge to widespread adoption.

Regulatory and Reimbursement Challenges

The regulatory landscape for peripheral vascular devices is another challenge that the market faces. The approval process for new devices is complex, requiring extensive clinical trials and data to meet the standards set by regulatory bodies such as the FDA. These lengthy and costly procedures can delay the introduction of new technologies to the market, slowing down innovation. Furthermore, reimbursement policies for peripheral vascular procedures are subject to change, and coverage may vary across insurers. Inconsistent reimbursement rates can discourage healthcare providers from adopting newer technologies or limit patient access to treatments. As a result, navigating regulatory requirements and ensuring consistent reimbursement remains a significant hurdle for companies in the peripheral vascular device market.

Market Opportunities

Growing Demand for Non-Invasive and Advanced Treatment Options

The U.S. Peripheral Vascular Devices market presents significant opportunities driven by the growing demand for non-invasive and advanced treatment options. As healthcare continues to shift towards less invasive procedures, there is an increasing need for devices that support minimally invasive treatments for peripheral artery disease (PAD) and other vascular conditions. Technological advancements, such as drug-eluting stents, bioresorbable scaffolds, and next-generation catheters, are opening up new opportunities for companies to develop and introduce innovative solutions. These advanced devices not only improve treatment outcomes but also reduce recovery times and minimize complications, positioning them as attractive options for healthcare providers and patients. The continued development of cutting-edge technologies in this space offers substantial growth potential, particularly as patient preferences shift towards procedures with fewer risks and shorter recovery periods.

Expansion into Outpatient and Ambulatory Care Settings

Another significant market opportunity lies in the expansion of peripheral vascular device use in outpatient and ambulatory care settings. As more peripheral vascular procedures move from hospitals to outpatient clinics and ambulatory surgical centers, the demand for affordable, efficient, and effective devices is rising. These care settings offer cost-effective alternatives to traditional hospital-based treatments, benefiting both patients and healthcare systems. Companies that can adapt their devices to meet the specific needs of outpatient care, such as reducing procedure times and simplifying device usage, will likely see increased adoption. Moreover, as healthcare facilities continue to embrace these settings for peripheral vascular interventions, the market for related devices is poised for growth, presenting a promising opportunity for manufacturers in this sector.

Market Segmentation Analysis:

By Type:

The U.S. Peripheral Vascular Devices market is segmented by type, with angioplasty balloons, angioplasty stents, catheters, guidewires, and other devices forming the key categories. Angioplasty balloons and angioplasty stents hold the largest market share, driven by their crucial role in treating peripheral artery disease (PAD). These devices are used to open blocked arteries and prevent restenosis, improving blood flow and reducing complications. Catheters and guidewires are essential for vascular interventions, enabling physicians to navigate arteries and deliver treatments effectively. These devices continue to see widespread use due to their versatility in a range of vascular procedures. Additionally, the “Others” category includes a variety of specialized devices such as thrombectomy tools, used for clot removal, and bioresorbable devices, which are gaining traction for their ability to support vessel healing without long-term implants. The growing preference for minimally invasive techniques is driving the demand for these devices, which is expected to continue to fuel market growth in the coming years.

By End-user:

The U.S. Peripheral Vascular Devices market is also segmented based on end-users, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals remain the dominant end-user segment due to their large-scale infrastructure and comprehensive treatment capabilities. However, ambulatory surgical centers are rapidly gaining market share as healthcare shifts toward outpatient care. These centers offer cost-effective alternatives to traditional hospital settings, providing patients with quicker recovery times and lower treatment costs. Specialty clinics, which focus on vascular conditions, are also experiencing growth, as they provide specialized care and advanced treatment options for patients with peripheral vascular diseases. The expansion of outpatient and specialized care settings is reshaping the market landscape, presenting opportunities for manufacturers to tailor their devices for use in these environments. As more procedures move out of hospitals, the demand for efficient, easy-to-use devices suitable for outpatient settings is expected to rise, supporting the continued growth of these segments.

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • Western United States
  • Midwestern United States
  • Southern United States
  • Northeastern United States

Regional Analysis

Western United States

The Western United States holds the largest market share of 33% in the U.S. Peripheral Vascular Devices market, driven by the region’s advanced healthcare infrastructure, high adoption of new medical technologies, and a significant elderly population prone to vascular diseases. States such as California, Washington, and Oregon have some of the highest concentrations of hospitals, outpatient surgical centers, and specialty clinics, contributing to the increased demand for peripheral vascular devices. Additionally, the region is home to several key medical device manufacturers and research institutions, further driving innovation and market growth. The Western U.S. also benefits from a growing focus on minimally invasive procedures, such as angioplasty, which are increasingly preferred due to shorter recovery times and reduced risks, thereby supporting further expansion of the market.

Southern United States

The Southern United States represents 28% of the market share in the U.S. Peripheral Vascular Devices market. This region has a high prevalence of lifestyle-related risk factors such as obesity, diabetes, and hypertension, which are leading contributors to peripheral artery disease (PAD). States like Texas, Florida, and Georgia have a large aging population, which further drives the need for vascular treatments. The Southern U.S. has seen significant investments in healthcare facilities and outpatient care centers, expanding the accessibility of advanced vascular treatments. As healthcare policies in this region continue to evolve and access to cutting-edge medical technologies improves, the demand for peripheral vascular devices is expected to grow, providing opportunities for market players.

Northeastern United States

The Northeastern United States holds 22% of the U.S. Peripheral Vascular Devices market share, with states like New York, Massachusetts, and Pennsylvania being key contributors. This region boasts some of the leading hospitals and medical institutions in the country, supporting the high adoption of advanced medical technologies. The Northeastern U.S. has a large, diverse population with a growing number of elderly individuals, which increases the demand for treatments related to vascular diseases. The region also leads in research and development, with a focus on innovation in vascular devices such as drug-eluting stents and bioresorbable scaffolds. As the healthcare sector continues to expand, the market for peripheral vascular devices is expected to experience continued growth in this region.

Midwestern United States

The Midwestern United States, accounting for 17% of the market share, is witnessing steady growth in the peripheral vascular devices market. This region has a high incidence of PAD, which is directly influencing the demand for vascular interventions. States such as Illinois, Ohio, and Michigan are focusing on improving healthcare access, especially in rural areas, where the adoption of peripheral vascular devices is gaining traction. With an increasing number of outpatient surgical centers and specialty clinics offering advanced vascular treatments, the demand for devices like angioplasty balloons, stents, and catheters is on the rise. The growing focus on preventive healthcare and early diagnosis is likely to drive further expansion in the market for peripheral vascular devices across the Midwest.

Key Player Analysis

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Becton, Dickinson and Company
  • Cardinal Health
  • Cook Medical
  • Koninklijke Philips N.V.
  • AngioDynamics, Inc.
  • Biotronik SE & Co. KG

Competitive Analysis

The competitive landscape of the U.S. Peripheral Vascular Devices market is dominated by leading players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Cook Medical, Koninklijke Philips N.V., AngioDynamics, Inc., and Biotronik SE & Co. KG. These players are focused on product development and technological advancements to meet the increasing demand for minimally invasive treatments. For instance, Abbott Laboratories has been actively involved in developing advanced vascular devices, including drug-eluting stents and bioresorbable scaffolds. Companies are introducing new devices, such as drug-eluting stents, bioresorbable scaffolds, and advanced catheters, to enhance treatment efficacy and improve patient outcomes. Strategic partnerships, mergers, and acquisitions are common strategies used to expand product portfolios and strengthen market positions. Additionally, companies are increasingly focusing on enhancing their presence in outpatient surgical centers and specialty clinics, responding to the growing trend of moving vascular procedures from hospitals to more cost-effective settings. The development of devices catering to both inpatient and outpatient care settings is crucial for staying competitive. Market players also emphasize research and development to address specific patient needs and offer customized solutions, creating differentiation in an increasingly saturated market. The competitive landscape is expected to remain dynamic, with continuous innovation and collaboration driving growth in the peripheral vascular devices sector.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The U.S. Peripheral Vascular Devices market exhibits a moderately concentrated structure, dominated by a few key players who lead in innovation and market share. These companies focus on product development and technological advancements, such as drug-eluting stents, bioresorbable scaffolds, and next-generation catheters, to maintain their competitive edge. Despite the dominance of large players, there is also room for smaller, specialized companies that focus on niche products or innovative solutions, especially in areas like imaging technologies and specialized vascular interventions. The market is characterized by rapid technological advancements, with ongoing research and development driving the introduction of novel devices that offer improved clinical outcomes and reduced procedural risks. Additionally, there is a notable trend toward the increasing shift of peripheral vascular procedures to outpatient settings, which is reshaping the market dynamics. Companies are adapting their strategies to provide devices that cater to both inpatient and outpatient care environments, enabling broader market access. Furthermore, regulatory requirements and pricing pressures play a crucial role in shaping the market’s characteristics, influencing product development cycles and the overall competitive landscape. The market’s concentration and the pace of innovation ensure continued growth, although smaller companies may face challenges related to market entry and scalability.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The market will see increased investment in research and development, especially in bioresorbable and drug-eluting devices, to address complex vascular conditions.
  2. Advancements in imaging technologies will enhance the accuracy of peripheral vascular procedures, contributing to better clinical outcomes.
  3. There will be growing adoption of AI and robotics in vascular procedures, improving procedural efficiency and reducing complications.
  4. The aging population in the U.S. will continue to be a major factor in driving demand for peripheral vascular devices as older adults are more prone to vascular diseases.
  5. Increasing focus on personalized medicine will lead to the development of devices tailored to individual patient needs and specific vascular conditions.
  6. The rise of telemedicine and remote monitoring will complement peripheral vascular treatments, providing ongoing care and enhancing patient management post-procedure.
  7. Regulatory bodies will likely streamline approval processes for new vascular devices, expediting their introduction to the market.
  8. As healthcare systems push for more cost-effective solutions, manufacturers will invest in developing affordable devices without compromising quality.
  9. The integration of digital health solutions into vascular treatments will continue to grow, improving patient outcomes and providing real-time monitoring capabilities.
  10. Expansion into emerging markets may become a priority for key players to capitalize on the growing demand for vascular interventions globally.

CHAPTER NO. 1 : INTRODUCTION 18
1.1.1. Report Description 18
Purpose of the Report 18
USP & Key Offerings 18
1.1.2. Key Benefits for Stakeholders 18
1.1.3. Target Audience 19
1.1.4. Report Scope 19
CHAPTER NO. 2 : EXECUTIVE SUMMARY 20
2.1. Peripheral Vascular Devices Market Snapshot 20
2.1.1. U.S. Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 21
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 22
3.1. Russia-Ukraine and Israel-Palestine War Impacts 22
CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 23
4.1. Introduction 23
4.2. Market Drivers 24
4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 24
4.2.2. Technological advancements in minimally invasive procedures 25
4.3. Market Restraints 26
4.3.1. High cost of peripheral vascular devices and associated procedures 26
4.4. Market Opportunities 27
4.4.1. Growing demand for peripheral vascular devices in emerging economies 27
4.5. Porter’s Five Forces Analysis 28
4.6. Buying Criteria 29
CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 30
5.1. Import Analysis by U.S. 30
5.1.1. U.S. Peripheral Vascular Devices Market Import Volume/Revenue, By U.S., 2018 – 2023 30
5.2. Export Analysis by U.S. 31
5.2.1. U.S. Peripheral Vascular Devices Market Export Volume/Revenue, By U.S., 2018 – 2023 31
CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 32
6.1. Demand Analysis by U.S. 32
6.1.1. U.S. Peripheral Vascular Devices Market Demand Volume/Revenue, By U.S., 2018 – 2023 32
6.2. Supply Analysis by U.S. 33
6.2.1. U.S. Peripheral Vascular Devices Market Supply Volume/Revenue, By U.S., 2018 – 2023 33
CHAPTER NO. 7 : PRODUCTION ANALYSIS 34
7.1. Production Analysis by U.S. 34
7.1.1. U.S. Peripheral Vascular Devices Market Production Volume/Revenue, By U.S., 2018 – 2023 34
CHAPTER NO. 8 : PRICE ANALYSIS 35
8.1. Price Analysis by Type 35
8.1.1. U.S. Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 35
8.1.2. U.S. Type Market Price, By Type, 2018 – 2023 35
CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 36
9.1. Key Raw Materials and Suppliers 36
9.2. Key Raw Materials Price Trend 36
CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 37
10.1. Manufacturing Cost Analysis 37
10.2. Manufacturing Process 37
CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 38
11.1. Company Market Share Analysis – 2023 38
11.2. Value Chain Analysis 38
11.2.1. U.S. Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 39
11.2.2. U.S. Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 40
11.2.3. U.S. Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 40
11.2.4. U.S. Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 41
11.3. U.S. Peripheral Vascular Devices Market Company Volume Market Share, 2023 42
11.4. U.S. Peripheral Vascular Devices Market Company Revenue Market Share, 2023 43
11.5. Company Assessment Metrics, 2023 43
11.5.1. Stars 43
11.5.2. Emerging Leaders 43
11.5.3. Pervasive Players 43
11.5.4. Participants 43
11.6. Start-ups /SMEs Assessment Metrics, 2023 43
11.6.1. Progressive Companies 43
11.6.2. Responsive Companies 44
11.6.3. Dynamic Companies 44
11.6.4. Starting Blocks 44
11.7. Strategic Developments 45
11.7.1. Acquisitions & Mergers 45
New Product Launch 45
U.S. Expansion 45
11.8. Key Players Product Matrix 46
CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 47
12.1. PESTEL 47
12.1.1. Political Factors 47
12.1.2. Economic Factors 47
12.1.3. Social Factors 47
12.1.4. Technological Factors 47
12.1.5. Environmental Factors 47
12.1.6. Legal Factors 47
12.2. Adjacent Market Analysis 47
CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 48
13.1. Peripheral Vascular Devices Market Overview, by Type Segment 48
13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 49
13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 50
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 50
13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 51
13.2. Angioplasty Balloons 52
13.3. Angioplasty Stents 53
13.4. Catheters 54
13.5. Guidewires 55
13.6. Others 56
CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 57
14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 57
14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 58
14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 59
14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 59
14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 60
14.2. Hospitals 61
14.3. Ambulatory Surgical Centers 62
14.4. Specialty Clinics 63
CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – U.S. ANALYSIS 64
15.1. Type 64
15.1.1. U.S. Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 64
15.2. U.S. Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 64
15.3. End-user 65
15.3.1. U.S. Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 65
15.3.2. U.S. Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 65
CHAPTER NO. 16 : COMPANY PROFILES 66
16.1. Abbott Laboratories 66
16.1.1. Company Overview 66
16.1.2. Product Portfolio 66
16.1.3. Swot Analysis 66
16.1.4. Business Strategy 67
16.1.5. Financial Overview 67
16.2. Boston Scientific Corporation 68
16.3. Medtronic plc 68
16.4. Terumo Corporation 68
16.5. Becton, Dickinson and Company 68
16.6. Cardinal Health 68
16.7. Cook Medical 68
16.8. Koninklijke Philips N.V. 68
16.9. AngioDynamics, Inc. 68
16.10. Biotronik SE & Co. KG 68

List of Figures
FIG NO. 1. U.S. Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for U.S. Peripheral Vascular Devices Market 29
FIG NO. 3. U.S. Peripheral Vascular Devices Market Import Volume/Revenue, By U.S., 2018 – 2023 31
FIG NO. 4. U.S. Peripheral Vascular Devices Market Export Volume/Revenue, By U.S., 2018 – 2023 32
FIG NO. 5. U.S. Peripheral Vascular Devices Market Demand Volume/Revenue, By U.S., 2018 – 2023 33
FIG NO. 6. U.S. Peripheral Vascular Devices Market Supply Volume/Revenue, By U.S., 2018 – 2023 34
FIG NO. 7. U.S. Peripheral Vascular Devices Market Production Volume/Revenue, By U.S., 2018 – 2023 35
FIG NO. 8. U.S. Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36
FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37
FIG NO. 10. Manufacturing Cost Analysis 38
FIG NO. 11. Manufacturing Process 38
FIG NO. 12. Value Chain Analysis for U.S. Peripheral Vascular Devices Market 39
FIG NO. 13. Company Share Analysis, 2023 40
FIG NO. 14. Company Share Analysis, 2023 41
FIG NO. 15. Company Share Analysis, 2023 41
FIG NO. 16. Company Share Analysis, 2023 42
FIG NO. 17. Peripheral Vascular Devices Market – Company Volume Market Share, 2023 43
FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44
FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 20. Market Attractiveness Analysis, By Type 51
FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 23. U.S. Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. U.S. Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. U.S. Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. U.S. Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. U.S. Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, By End-user 60
FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60
FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
FIG NO. 32. U.S. Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. U.S. Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63
FIG NO. 34. U.S. Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables
TABLE NO. 1. : U.S. Peripheral Vascular Devices Market: Snapshot 18
TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 22
TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 24
TABLE NO. 4. : U.S. Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 34
TABLE NO. 5. : Key Raw Materials & Suppliers 35
TABLE NO. 6. : U.S. Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 89
TABLE NO. 7. : U.S. Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 89
TABLE NO. 8. : U.S. Peripheral Vascular Devices Market Revenue, By Application, 2018 – 2023 (USD Million) 90
TABLE NO. 9. : U.S. Peripheral Vascular Devices Market Revenue, By Application, 2024 – 2032 (USD Million) 90
TABLE NO. 10. : U.S. Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 91
TABLE NO. 11. : U.S. Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 91
TABLE NO. 12. : U.S. Peripheral Vascular Devices Market Revenue, By Technology, 2018 – 2023 (USD Million) 92
TABLE NO. 13. : U.S. Peripheral Vascular Devices Market Revenue, By Technology, 2024 – 2032 (USD Million) 92
TABLE NO. 14. : U.S. Peripheral Vascular Devices Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93
TABLE NO. 15. : U.S. Peripheral Vascular Devices Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions:

What is the current size of the U.S. Peripheral Vascular Devices market?

The U.S. Peripheral Vascular Devices market was valued at USD 2,945.00 million in 2023 and is projected to grow to USD 4,947.26 million by 2032, reflecting a CAGR of 6.70%.

What factors are driving the growth of the U.S. Peripheral Vascular Devices market?

The market growth is driven by the increasing prevalence of peripheral artery disease (PAD), an aging population, advancements in minimally invasive technologies, supportive reimbursement policies, and a shift toward outpatient and ambulatory care settings.

What are the key segments within the U.S. Peripheral Vascular Devices market?

Key segments include angioplasty balloons, angioplasty stents, catheters, guidewires, and other specialized devices such as thrombectomy tools and bioresorbable devices. End-user categories consist of hospitals, ambulatory surgical centers, and specialty clinics.

What are some challenges faced by the U.S. Peripheral Vascular Devices market?

Challenges include the high cost of advanced devices, complex regulatory requirements, lengthy approval processes, and reimbursement uncertainties that can limit accessibility and slow the adoption of innovative technologies.

Who are the major players in the U.S. Peripheral Vascular Devices market?

Prominent players include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Cook Medical, Koninklijke Philips N.V., AngioDynamics, Inc., and Biotronik SE & Co. KG. These companies focus on innovation, strategic partnerships, and expanding their product portfolios to maintain competitive market positions.

U.S. AI in Finance Market

Published:
Report ID: 75275

U.S. AC-DC Power Supply in Data Center Market

Published:
Report ID: 74818

U.S. Interior Design Market

Published:
Report ID: 74675

U.S. Artificial Intelligence in Retail Market

Published:
Report ID: 73774

U.S. Data Center Physical Security Market

Published:
Report ID: 73756

U.S. Grid Modernization Market

Published:
Report ID: 73492

U.S. Hummus Market

Published:
Report ID: 73454

U.S. Data Center Uninterruptable Power Supply (UPS) Market

Published:
Report ID: 73226

U.S. Data Center Processor Market

Published:
Report ID: 73217

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Malignant Pleural Effusion Market

Published:
Report ID: 74366

Angiography Imaging Systems Market

Published:
Report ID: 74155

Electrosurgery Accessories Market

Published:
Report ID: 74130

Digital Psychotherapeutics Market

Published:
Report ID: 73007

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN